Praxis Precision Medicines I Share Price Today
(NASDAQ: PRAX)

Name: Praxis Precision Medicines I Share Price (NASDAQ: PRAX) - Stock Quote, Live Chart
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Praxis Precision Medicines I share price is $35.12 & ₹2,964.74 as on 7 May 2025, 2.30 'hrs' IST

$35.12

▲

-3.84

(-9.86%)

Market is closed - opens 7 PM, 07 May 2025

View live Praxis Precision Medicines I share price in Dollar and Rupees. Guide to invest in Praxis Precision Medicines I stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Praxis Precision Medicines I, along with analyst recommendations, forecasts, and comprehensive financials.

Praxis Precision Medicines I share price movements

Today's Low: $34.94
Today's High: $37.67
$35.12
0.51%
Downside
Day's Volatility :7.23%
Upside
6.76%
52 Weeks Low: $26.70
52 Weeks High: $91.83
$35.12
23.97%
Downside
52 Weeks Volatility :70.92%
Upside
61.76%

Praxis Precision Medicines I (PRAX) Returns

Period	Praxis Precision Medicines I	Sector (Health Care)	Index (Russel 2000)
3 Months	-55.76%	-5.7%	0.0%
6 Months	-45.69%	-7.4%	0.0%
1 Year	-25.51%	-3.1%	0.0%
3 Years	-64.79%	6.4%	-3.8%

Praxis Precision Medicines I (PRAX) Key Statistics

in dollars & INR

Previous Close	$38.96
Open	$37.57
Today's High	$37.665
Today's Low	$34.94
Market Capitalization	$819.6M
Today's Volume	$432.0K
52 Week High	$91.83
52 Week Low	$26.7
Revenue TTM	$8.1M
EBITDA	$-232.7M
Earnings Per Share (EPS)	$-10.21
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-63.56%

How to invest in Praxis Precision Medicines I Stock (PRAX) from India?

It is very easy for Indian residents to invest directly in Praxis Precision Medicines I from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Praxis Precision Medicines I stock in both Indian Rupees (INR) and US Dollars (USD). Search for Praxis Precision Medicines I or PRAX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Praxis Precision Medicines I or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Praxis Precision Medicines I shares which would translate to 0.024 fractional shares of Praxis Precision Medicines I as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Praxis Precision Medicines I, in just a few clicks!

Returns in Praxis Precision Medicines I (PRAX) for Indian investors in Rupees

The Praxis Precision Medicines I stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Praxis Precision Medicines I investment value today

Current value as on today

₹68,156

Returns

₹31,844

(-31.84%)

Returns from Praxis Precision Medicines I Stock

₹32,977 (-32.98%)

Dollar Returns

₹1,133 (+1.13%)

Indian investors sentiment towards Praxis Precision Medicines I (PRAX)

-74%

Period: Apr 6, 2025 to May 6, 2025. Change in 30 Days versus previous period

Search interest for Praxis Precision Medicines I Stock from India on INDmoney has decreased by -74% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Praxis Precision Medicines I

Cormorant Asset Management, LLC
8.40%
BlackRock Inc
7.25%
Perceptive Advisors LLC
6.59%
T. Rowe Price Associates, Inc.
5.99%
Morgan Stanley - Brokerage Accounts
5.77%
Vanguard Group Inc
5.28%

Analyst Recommendation on Praxis Precision Medicines I

Rating

Trend

Buy

83%Buy

16%Hold

0%Sell

Based on 12 Wall street analysts offering stock ratings for Praxis Precision Medicines I(by analysts ranked 0 to 5 stars)

Analyst Forecast on Praxis Precision Medicines I Stock (PRAX)

What analysts predicted

Upside of 181.37%

Target:

$98.82

Current:

$35.12

Insights on Praxis Precision Medicines I Stock (Ticker Symbol: PRAX)

Price Movement
In the last 3 months, PRAX stock has moved down by -55.1%
PRAX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 77.4% return, outperforming this stock by 102.9%
PRAX vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 103.2% return, outperforming this stock by 171.0%
Price to Sales
ForPRAX every $1 of sales, investors are willing to pay $85.2, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.8 for every $1 of sales.

Praxis Precision Medicines I Technicals Summary

Sell

Neutral

Buy

Praxis Precision Medicines I is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Praxis Precision Medicines I (PRAX) Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Praxis Precision Medicines I	23.8%	-45.69%	-25.51%	-64.79%	-90.64%
Regeneron Pharmaceuticals, Inc.	5.41%	-26.07%	-37.76%	0.66%	7.16%
Beone Medicines Ltd	15.39%	25.53%	58.5%	89.61%	62.29%
Vertex Pharmaceuticals Incorporated	5.31%	1.24%	21.82%	112.65%	83.99%
Alnylam Pharmaceuticals, Inc.	17.53%	0.29%	77.41%	123.47%	101.12%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Praxis Precision Medicines I	NA	NA	NA	-12.52	-0.64	-0.4	NA	21.59
Regeneron Pharmaceuticals, Inc.	15.39	15.39	1.3	35.79	0.16	0.07	0.01	277.5
Beone Medicines Ltd	NA	NA	NA	1.06	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.37	17.94	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	1.07	-15.01	-0.02	NA	0.89

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Praxis Precision Medicines I	Buy	$819.6M	-90.64%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$65.4B	7.16%	15.39	31.94%
Beone Medicines Ltd	NA	$29.5B	62.29%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$128.8B	83.99%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$33.6B	101.12%	NA	-11.49%

About Praxis Precision Medicines I

Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, engages in the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance. The company's platforms include cerebrum, a small molecule platform for CNS small molecule therapies to develop orally available precision therapies; and solidus to discover and develop antisense oligonucleotide. It also develops Ulixacaltamide, a small molecule inhibitor of T-type calcium channels that is in Phase 3 clinical trial for the treatment of essential tremor; Vormatrigine, a small molecule targeting the hyperexcitable state of sodium-channels in the brain to treat focal onset epilepsy; Relutrigine for the treatment of developmental and epileptic encephalopathies; PRAX-020 to treat KCNT1; and PRAX-050. In addition, the company develops Elsunersen, a clinical-stage ASO designed to regulate NaV1.2 expression for the treatment of SCN2A-DEE; PRAX-080 that targets PCDH19-related developmental epilepsy; PRAX-090 for targeting SYNGAP1 loss-of-function; and PRAX-100 that targets SCN2A LoF mutations. It has a license agreement with RogCon Inc.; and research collaboration and license agreement with Ionis Pharmaceuticals, Inc. Praxis Precision Medicines, Inc. was incorporated in 2015 and is based in Boston, Massachusetts.

Organization	Praxis Precision Medicines I
Employees	116
CEO	Mr. Marcio Silva De'Souza M.B.A.
Industry	Health Technology

Management People of Praxis Precision Medicines I

Name	Title
Mr. Marcio Silva De'Souza M.B.A.	President, CEO & Director
Mr. Timothy Edwin Kelly	CFO & Treasurer
Mr. Alex Nemiroff J.D.	General Counsel & Secretary
Dr. Steven Petrou B.Sc. (Hons.), Ph.D.	Co-Founder & Chief Scientific Officer
Lauren Mastrocola	VP of Finance & Principal Accounting Officer
Dr. Karl Hansen Ph.D.	Chief Technical Operations Officer
Mr. Alex Kane	VP of Investor Relations & Corporate Communications
Ms. Kelly McCue	Chief People Officer
Ms. Alyssa J. S. Wyant	Chief Regulatory & Quality Officer
Ms. Megan T. Sniecinski	Chief Business Officer

Important FAQs about investing in PRAX Stock from India :

What is Praxis Precision Medicines I share price today?

Praxis Precision Medicines I share price today stands at $35.12, Open: $37.57 ; Previous Close: $38.96 ; High: $37.67 ; Low: $34.94 ; 52 Week High: $91.83 ; 52 Week Low: $26.70.

The stock opens at $37.57, after a previous close of $38.96. The stock reached a daily high of $37.67 and a low of $34.94, with a 52-week high of $91.83 and a 52-week low of $26.70.

Can Indians buy Praxis Precision Medicines I shares?

Yes, Indians can invest in the Praxis Precision Medicines I (PRAX) from India.

With INDmoney, you can buy Praxis Precision Medicines I at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Praxis Precision Medicines I at zero transaction cost.

How can I buy Praxis Precision Medicines I shares from India?

It is very easy to buy Praxis Precision Medicines I from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Praxis Precision Medicines I (PRAX) be purchased?

Yes, you can buy fractional shares of Praxis Precision Medicines I with INDmoney app.

What are the documents required to start investing in Praxis Precision Medicines I stocks?

To start investing in Praxis Precision Medicines I, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.